Showing results (71-80 of 77) with videos related to
Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 77 results.
The New England Journal of Medicine|June 5, 2023
Vorasidenib in IDH1- or IDH2-Mutant Low-Grade GliomaIngo K Mellinghoff, Martin J van den Bent, Deborah T Blumenthal, et al.The Lancet. Oncology|November 1, 2025
Vorasidenib in IDH1-mutant or IDH2-mutant low-grade glioma (INDIGO): secondary and exploratory endpoints from a randomised, double-blind, placebo-controlled, phase 3 trialTimothy F Cloughesy, Martin J van den Bent, Mehdi Touat, et al.Nature Communications|August 10, 2024
A real-world observation of patients with glioblastoma treated with a personalized peptide vaccinePauline Latzer, Henning Zelba, Florian Battke, et al.Cancer Discovery|October 12, 2023
Combined Immunotherapy Improves Outcome for Replication-Repair-Deficient (RRD) High-Grade Glioma Failing Anti-PD-1 Monotherapy: A Report from the International RRD ConsortiumAnirban Das, Nicholas R Fernandez, Adrian Levine, et al.Nature Medicine|January 7, 2022
Genomic predictors of response to PD-1 inhibition in children with germline DNA replication repair deficiencyAnirban Das, Sumedha Sudhaman, Daniel Morgenstern, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 4, 2021
Survival Benefit for Individuals With Constitutional Mismatch Repair Deficiency Undergoing SurveillanceCarol Durno, Ayse Bahar Ercan, Vanessa Bianchi, et al.The Lancet. Oncology|March 29, 2024
Clinical and biological landscape of constitutional mismatch-repair deficiency syndrome: an International Replication Repair Deficiency Consortium cohort studyAyse Bahar Ercan, Melyssa Aronson, Nicholas R Fernandez, et al.Pageof 8